The EPO shall have no liability whatsoever for any loss or damage to third parties resulting from the Licensee's or the EPO's performance pursuant to this Agreement.
欧洲专利局不会向任何第三方就被许可方或者欧洲专利局在本协议项下行为所引发的任何损失或损害承担任何责任。
The Licensee hereby releases the EPO from all third-party claims arising from the failure to make such corrections or the failure to do so in due time.
被许可方特此免除欧洲专利局由于未能进行纠正或者未能在适当时候进行纠正而遭受任何第三方提出的索赔。
The Licensee at its own expense, shall promote and market the Product(s) created with the use of information extracted from the Original EPO-Database(s).
被许可方应当自费推广和营销利用原始EPO数据库中提取的信息所创建的产品。
CONCLUSION: Simulated living high training low training is an effective way to improve aerobic performance, but the changing law of EPO is different from that of traditional altitude training.
结论：模拟高住低练是提高有氧能力的有效措施，但EPO的变化规律与传统高原训练不同。
Product "shall mean the Licensee's machine-readable databases and publications which contain data from the Original EPO-Databases and which are sold or licensed in accordance with this Agreement."
“产品”是指包含原始epo数据库数据并且根据本协议被销售或者许可的被许可方的机读格式数据库和出版物。
Results: The cumulative release of EPO from single layer minipellet and double layer minipellet reached 100% within 4 days and 7 days, respectively.
结果：单层微条和双层微条中的红细胞生成素分别在第4天和第7天完全释放。
The serum from anemic rats treated with naked plasmid expressing human EPO showed obvious neutralizing activity to inhibit the proliferation of BEF-2 cells.
在大鼠模型中，表达人EPO基因裸质粒组的血清有明显的中和活性，可抑制BEF-2细胞的增殖。
The serum from anemic rats treated with naked plasmid expressing human EPO showed obvious neutralizing activity to inhibit the proliferation of BEF-2 cells.
在大鼠模型中，表达人EPO基因裸质粒组的血清有明显的中和活性，可抑制BEF-2细胞的增殖。
应用推荐